Home | All primary_outcomes

[RDF data]
Primary Outcomes #10492

Resource URI: http://static.linkedct.org/resource/primary_outcomes/10492
rdfs:label Primary Outcomes #10492
linkedct:measure Immune persistence in terms of anti-HAV and anti-HBs antibodies and GMCs, 5 and 6 years after administration of first vaccine dose. An additional dose of the study vaccine will be given (between 6 to 12 months after the Year 6 time point) to subjects who
is linkedct:primary_outcomes of <http://static.linkedct.org/resource/trials/NCT00197171>
linkedct:primary_outcomes_id 10492 (xsd:int)
rdf:type linkedct:primary_outcomes